Acetaminophen Randomized Controlled Trial

Withdrawn before enrolling · Phase 3 · Has a placebo group

Conditions studied: Post Operative Pain

In brief

Patients that are to undergo isolated meniscectomy will be randomized to 2 cohorts: one will take the FDA recommended dose of acetominophen (1000mg) 24hrs before surgery, one will be given a similarly looking placebo pill. A multitude of post-op variables will be included, mainly pain scores and morphine equivalent doses at different time points.

Key facts

Study ID

NCT02737124

Run by

NYU Langone Health

People needed

0

Starts

2017-02-16

Expected to finish

2018-03-19

Last updated by the study team

2018-07-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be at least 18 years of age
• ASA Class I-II
• Patients scheduled for meniscectomy

You may not qualify if…

• Contraindication to acetaminophen (hypersensitivity, extensive alcohol history, liver disease, actively breastfeeding)
• Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects, dementia, etc.)
• Younger than 18 years of age or older than 65
• Any patient considered a vulnerable subject
• Patients on pain medication prior to surgery

Where it is running

• New York University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.